Strata Critical Medical (SRTA) Return on Capital Employed (2020 - 2026)

Strata Critical Medical has disclosed Return on Capital Employed across 7 years of filings, most recently posting 6.53% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 677.0% year-over-year to 6.53%; the TTM figure through Mar 2026 stood at 6.53% (up 677.0% YoY), while the FY2025 annual figure was 8.24%, up 66.0% from the prior year.
• Return on Capital Employed improved to 6.53% in Q1 2026, from 7.3% in the prior quarter.
• Over the last five years, Return on Capital Employed for SRTA reached as high as 6.53% in Q1 2026 and fell as low as 25.91% in Q2 2024.
• The 5-year median for Return on Capital Employed is 14.17% (2024), against an average of 15.47%.
• Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 1081 bps — and 2025, when it surged 1719 bps.
• A 5-year view of Return on Capital Employed shows it stood at 13.33% in 2022, then tumbled by 89 bps to 25.16% in 2023, then surged by 44 bps to 14.17% in 2024, then surged by 48 bps to 7.3% in 2025, then advanced by 11 bps to 6.53% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 6.53%, 7.3%, and 8.25% for Q1 2026, Q4 2025, and Q3 2025 respectively.